Salivary Gland Cancer UK shared a post on LinkedIn:
“Launching the RQ1 Clinician Survey: Assessing SGC Management Guidelines across the UK.
Following our recent presentation at BAHNO 2026, the Salivary Gland Cancer UK Research Working Group is officially launching our clinician survey for Research Question 1 (RQ1) : ‘Addressing the Utility of Guidelines for Oncological Management of Salivary Gland Malignancies’.
Because salivary gland malignancies are rare and histologically diverse, standardising care is incredibly complex. Clinical guidelines exist to ensure equity of care, but we need to understand how well they serve clinicians in daily practice and where the critical gaps lie.
Target Audience:
We are seeking insights from UK-based specialists currently managing these complex cases:
- Clinical and Medical Oncologists managing salivary gland malignancies with current practice in the UK.
- Surgeons (ENT and OMFS) managing SGCs with current practice in the UK (specifically regarding indications for adjuvant treatment and follow-up).
Why Your Input Matters:
Your clinical experience is vital to helping us map out the utility of current protocols. The data gathered from this survey will be used to advocate for more updated, comprehensive management pathways within head and neck oncology, ultimately aiming to support clinicians and improve long-term patient outcomes.
- How to participate: You can access the survey directly via the link below:
- Take the RQ1 Clinician Survey: RQ 1. Address the utility of Guidelines for Salivary Gland Cancers (SGC)
Please tag, share, and pass this along to any colleagues working within UK head and neck oncology networks!”
To which Kevin Harrington, Professor in Biological Cancer Therapies at Institute of Cancer Research, added:
“Calling all those out there who see patients with salivary gland cancer and, like me, wish that we had better options for them.
Please complete this important survey that is being conducted under the aegis of Salivary Gland Cancer UK.”
Other articles featuring Salivary Gland Cancer UK and Kevin Harrington on OncoDaily.
